NDC 55154-3563-00 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-3563
- Requested NDC
- 55154-3563-00
- Package NDCs from labels
- 55154-3563-0, 55154-3563-00
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-09-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-09-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-3563-0 | Levothyroxine Sodium | 10 in 1 BAG | TABLET | 10 | 8 | |
| 55154-3563-0 | Levothyroxine Sodium | 1 in 1 BLISTER PACK | TABLET | 1 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-3563 | LEVOTHYROXINE SODIUM TABLET [CARDINAL HEALTH 107, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20240906_31a31756-68aa-4e01-bbb1-9d181f8d9181.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC. | 5401e4ff-aa7a-3e97-e063-6294a90a24f0 | 2026-06-11 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 53e84179-fe2a-5696-e063-6394a90a8566 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966224 9J765S329G |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | 2f05947f-a489-4298-a871-90db75b2a6c5 | 2026-06-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Coupler LLC | 5383a4d8-319a-5bf6-e063-6294a90a5497 | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | abe173cc-1579-43a5-b12d-a31958d0a539 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 966248 966222 892246 966221 966224 966249 966220 966225 966253 9J765S329G |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | NCS HealthCare of KY, LLC dba Vangard Labs | fde4ea0c-152b-4b79-a6d8-2b0dbd9107aa | 2026-06-04 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Cardinal Health 107, LLC | 66a3bd4a-770b-4f67-bfa7-6d5e23f2ecbf | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 966222 892246 966221 966224 966220 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 53316e75-9897-4935-e063-6294a90a94cf | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966249 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 5852d874-1ebc-49ff-b6c2-1dd513fca784 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | c8ae9dc4-836f-4912-80d7-684fd374f40a | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 52cce695-4363-8a2c-e063-6294a90a1bbf | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | ANDA209713 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 52cd19e4-a4b3-ecee-e063-6394a90ac33b | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966225 9J765S329G |
| Humco Sodium Bicarbonate | SODIUM BICARBONATE | Humco Holding Group, Inc. | aeaa34f6-216d-49f3-8393-c7bda96a3e32 | 2026-05-26 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Select Consumer Group | 3ca80d74-1e8b-49d9-e063-6394a90a4312 | 2026-05-24 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | db5cba81-9ad5-42ad-ac9e-a967337630f2 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | d9ccea69-109d-44cf-927b-4ff67652b6a0 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 4f40db1e-3dd9-4c7b-93e6-64f0fd10d551 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 50978a14-fd72-4c76-927f-667a1f097b87 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | eb53dc23-8337-497e-b466-192f905563ed | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 6d65b528-f52b-4b5d-8b76-46fbd4576f99 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.